Inactive Instrument

Press Releases Össur hf. Other OTC

Equities

Embla Medical hf: Interim Report Q1 2024	04-23	AQ
Össur hf: Board Decisions Following the Annual General Meeting	03-13	AQ
Össur hf: Results of the Annual General Meeting	03-13	AQ
Össur hf: Candidates to the Board of Directors	03-10	AQ
Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024	02-28	AQ
Össur hf: Össur establishes new parent organization to be named Embla Medical	02-21	AQ
Össur hf: Annual General Meeting 13 March 2024	02-21	AQ
Össur hf: Annual Report 2023	01-30	AQ
Össur hf: Interim Report Q4 2023	01-30	AQ
Össur hf: Össur's total share capital following completion of capital increase of 6,636,122 shares	01-24	AQ
Össur hf: Össur acquires FIOR & GENTZ	01-16	AQ
Össur hf: Financial Calendar 2024	12-20	AQ
Össur hf: Major Shareholder Announcement	11-21	AQ
Össur hf: Interim report Q3 2023	24/10/23	AQ
Ukrainian medical professionals receive comprehensive training in the field of lower limb prosthetics	16/10/23	AQ
Össur : Össur R&D insights shared with leading inventors and innovators	14/09/23	PU
Össur : Scottish Enterprise provides R&D funding grant to Össur to develop upper limb prosthetics	06/09/23	PU
Össur hf: Interim Report Q2 2023	25/07/23	AQ
Össur Salutes Team Össur members' Exceptional Performance at 2023 World Para Athletics Championships in Paris	20/07/23	AQ
Össur hf: Össur Appoints Lukas Märklin as Chief Operating Officer	15/06/23	AQ

No results for this search